Posted by Michael Wonder on 12 Jun 2025
US FDA approves tablet formulation of BeOne’s Brukinsa for all approved indications
11 June 2025 - New formulation provides patients with a simplified dosing experience—reducing pill burden and enhancing ease of administration—while preserving flexible dosing options
BeOne Medicines today announced that the US FDA has approved a new tablet formulation of Brukinsa (zanubrutinib) for all five approved indications.
